Liver Damage From Bodybuilding Steroids: Which Compounds Carry the Highest Risk?

Bodybuilding steroids do not all stress the liver in the same way. The biggest divide is not simply “oral versus injectable,” although that matters. The more important distinction is whether the compound is a 17-alpha-alkylated anabolic steroid, a chemical modification that helps the drug survive first-pass metabolism and remain active when taken by mouth. That same modification is strongly linked to the liver problems most often seen in steroid-related drug-induced liver injury, including prolonged cholestatic jaundice, peliosis hepatis, hepatic adenomas, and, in some cases, liver cancer. Injectable non-alkylated testosterone esters appear less hepatotoxic overall, but they are not completely free of liver risk, especially with long-term misuse or when stacked with other drugs and supplements. ^[1][2]

That means the bodybuilding compounds with the highest liver risk are usually the classic oral 17-alpha-alkylated steroids and designer products that secretly contain similar agents. The compounds repeatedly associated with clinically important liver injury include stanozolol, oxymetholone, oxandrolone, methyltestosterone, methandienone, fluoxymesterone, danazol, and norethandrolone. They do not all carry identical risk, but they belong to the group most consistently linked to the severe cholestatic pattern that can leave users intensely jaundiced and itchy for weeks or even months. By contrast, esterified testosterones at the 17-beta position have only rarely been implicated in cholestasis and seem to cause liver injury at a much lower rate. ^[1][2][3]

So which compounds carry the highest practical liver risk for bodybuilders? Based on the pattern seen in LiverTox, review literature, and reported cases, the top tier includes stanozolol and oxymetholone, with methyltestosterone, methandienone, fluoxymesterone, and oxandrolone also firmly in the high-risk category. This does not mean one can safely “pick the least dangerous oral.” It means that when severe steroid-related liver injury shows up in clinics, these are the sorts of compounds that keep appearing. Some are notorious for causing a “bland cholestasis” picture, where bilirubin climbs dramatically, itching becomes extreme, and routine liver enzymes may look less impressive than the patient’s symptoms would suggest. That mismatch can falsely reassure users who are only watching alanine aminotransferase and aspartate aminotransferase levels. ^[1][2][4]

Stanozolol deserves special attention because it appears again and again in severe case reports. It is a 17-alpha-alkylated synthetic anabolic steroid, and published cases describe marked jaundice, prolonged cholestasis, relatively modest enzyme elevation, kidney complications from bile cast nephropathy, and very slow recovery after discontinuation. This is one reason a steroid user can feel fine about “just one oral cycle” and still end up with a dangerous liver problem. The injury is not always a classic hepatitis picture. Sometimes the liver cells are not exploding with inflammation; instead, bile flow is disrupted so dramatically that bilirubin rises to alarming levels. ^[1][4][5]

Oxymetholone also sits near the top of the danger list. LiverTox notes that serum enzyme elevations have been closely linked to danazol and oxymetholone, and the broader androgenic steroid literature places oxymetholone among the alkylated agents most associated with clinically significant liver injury. In practical terms, that makes oxymetholone one of the bodybuilding steroids most likely to trigger concern for both short-term hepatotoxicity and longer-term structural liver complications when misused. ^[1][2]

Oxandrolone is sometimes discussed online as though it were “milder,” but that reputation can be misleading. It is still a 17-alpha-alkylated anabolic steroid. Even when a compound is marketed as cleaner, drier, or easier to tolerate, that does not remove the liver risk built into the chemistry. The same warning applies to methandienone and fluoxymesterone. These are not fringe compounds in the hepatotoxicity literature. They belong to the same family that is strongly associated with cholestasis, vascular liver injury, benign liver tumors, and malignant transformation in long-term or repeated exposure. ^[1][2][3]

The reason these compounds are more dangerous is not only that they are steroids. It is that 17-alpha-alkylation slows hepatic metabolism, which improves oral bioavailability but also increases hepatotoxic potential. Reviews on anabolic steroid-induced hepatotoxicity repeatedly emphasize that 17-alpha-alkylated anabolic steroids are the ones that appear hepatotoxic, whereas non-alkylated anabolic steroids appear far less so. That does not make injectable testosterone use safe from a whole-body perspective, but it helps explain why liver specialists focus so strongly on the oral alkylated compounds when severe steroid jaundice or steroid-related liver tumors are being discussed. ^[2][3]

Another important point is that bodybuilding supplements may contain undeclared anabolic steroids, so the user may not even know which liver-toxic compound was taken. In a study of 44 young men with bodybuilding supplement-related liver injury, patients uniformly showed a cholestatic pattern and often recovered slowly. Chemical analysis found anabolic steroids in products that did not clearly identify them on the label. Separate review data on supplement adulteration also show that anabolic steroids can appear in a substantial share of contaminated sports supplements. So the question is not only “which steroid is riskiest?” It is also “did the label even tell you what was inside?” ^[5][6]

When liver damage from bodybuilding steroids occurs, it can show up in four broad ways. The first is a mild rise in liver enzymes that may settle after discontinuation. The second, and the most classic, is acute cholestatic syndrome, often called bland cholestasis. The third is peliosis hepatis, a vascular injury pattern in which blood-filled cystic spaces form within the liver. The fourth is the development of hepatic tumors, including hepatic adenomas and sometimes hepatocellular carcinoma. These more serious outcomes are most closely linked to the alkylated anabolic steroids, particularly with prolonged or repeated exposure. ^[1][2][7]

Cholestatic injury is often the pattern that surprises users because it does not always behave like the liver damage people expect. The onset usually develops within one to four months after starting therapy, though it may occur later. Symptoms often begin gradually with fatigue, nausea, poor appetite, itching, dark urine, and then obvious jaundice. What makes this pattern so deceptive is that bilirubin can become severely elevated while transaminases remain only mildly abnormal. Someone may think, “My liver enzymes are not that bad,” while clinically significant liver injury is already unfolding. ^[1][8]

The structural liver complications are even more concerning. Peliosis hepatis has been repeatedly linked to anabolic steroid exposure and can lead to hemorrhage or liver failure. Hepatic adenomas are benign tumors, but they can bleed, recur, and in some cases undergo malignant transformation. In men, hepatic adenomas are relatively uncommon in the general population, so when they do appear, anabolic steroid exposure is a major red flag. The literature also includes reports of hepatocellular carcinoma in bodybuilders with extensive anabolic steroid abuse. These are not the most common outcomes, but they are the outcomes that make the phrase “just elevated liver enzymes” far too casual for this topic. ^[1][7][9]

A useful way to think about relative risk is this: the highest liver risk sits with oral 17-alpha-alkylated steroids and unknown supplement blends, the middle risk sits with products that may be mislabeled or stacked with other hepatotoxic agents, and the lower liver-specific risk sits with non-alkylated injectable testosterone preparations. Lower does not mean low overall. It means lower from a liver toxicity standpoint. Long-term testosterone misuse still carries broader cardiovascular, endocrine, reproductive, renal, and psychiatric risks, and even testosterone-based regimens can contribute to liver tumors over time, though seemingly at a lower rate than the classic alkylated orals. ^[1][2]

Users often make three mistakes that increase liver danger. The first is assuming that injectable use means no liver risk, which is not true. The second is assuming a steroid is safe because it is popular, “mild,” or commonly discussed in physique circles. The third is trusting over-the-counter bodybuilding supplements that may contain hidden hormones. In real-world cases of bodybuilding supplement liver injury, patients frequently do not present with a neat pharmacy label and a single known drug. They present after using blends, stacks, support products, and unlabeled supplements, which makes the liver injury both harder to trace and easier to underestimate. ^[5][6]

The warning signs that should never be ignored are persistent itching, yellow eyes or skin, dark urine, pale stools, nausea, fatigue, abdominal discomfort, loss of appetite, and unexplained swelling or sudden illness during or after a steroid cycle. If severe jaundice develops, this is not a wait-and-watch situation. Bland cholestasis from anabolic steroids can be prolonged even after the drug is stopped, and some patients need hospitalization because of intense pruritus, worsening bilirubin, or associated complications such as kidney injury. ^[1][4][8]

For readers wondering whether liver blood tests are enough, the answer is not always. Routine aminotransferase levels can miss the severity of cholestatic steroid injury. Clinicians usually need a broader assessment that may include bilirubin, alkaline phosphatase, gamma-glutamyl transferase, coagulation markers, kidney function, medication and supplement history, viral hepatitis testing, and, in selected cases, imaging or liver biopsy. That is why self-monitoring through casual online “cycle support” advice can fail badly. ^[1][4]

Which anabolic steroid is hardest on the liver, do oral steroids cause liver failure, is oxandrolone safer for the liver, or which bodybuilding compound causes jaundice. The evidence-based answer is that the liver danger clusters around the 17-alpha-alkylated oral anabolic steroids, especially compounds such as stanozolol and oxymetholone, with methyltestosterone, methandienone, fluoxymesterone, and oxandrolone also firmly in the high-risk group. The exact ranking can vary by dose, duration, stacking, contamination, individual susceptibility, and coexisting disease, but the class effect is strong enough that no one should interpret a “less risky” oral steroid as a liver-safe option. ^[1][2][3]

The bottom line is simple. The bodybuilding steroids with the highest liver risk are the oral 17-alpha-alkylated compounds and any supplement that may secretly contain them. Among the best-known offenders are stanozolol, oxymetholone, methyltestosterone, methandienone, fluoxymesterone, and oxandrolone. These drugs are linked not only to elevated liver tests, but also to prolonged cholestatic jaundice, peliosis hepatis, hepatic adenomas, and, in rare but serious cases, hepatocellular carcinoma. Injectable non-alkylated testosterones are generally less hepatotoxic, but they are not harmless and should not be framed as “safe for the liver.” The most dangerous misconception in bodybuilding is not that steroids have side effects. It is believing that liver damage announces itself early, clearly, and only with sky-high transaminases. Often, it does not. ^[1][2][7][9]

References: